Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ABCA9 antisense RNA 1 (ABCA9-AS1) is a long non-coding RNA transcribed from the ABCA9 locus in the reverse (antisense) direction, classified as a natural antisense transcript and located within a genomic region on chromosome 17q24.2[6]. Antisense RNAs typically regulate gene expression, often affecting the corresponding sense gene (ABCA9), and may have roles in transcriptional interference or epigenetic regulation, but the specific biological functions of ABCA9-AS1 remain uncharacterized. As a non-protein coding gene, it is not considered a therapeutic target, receptor, nor is it associated with interacting drugs or mechanisms of action, and there is no clinical biomarker evidence for this transcript[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ABCA9 antisense RNA 1 (ABCA9-AS1).